Update to Liquidia’s Participation in the Jefferies Healthcare Conference
07 juin 2022 16h30 HE
|
Liquidia Corporation
MORRISVILLE, N.C., June 07, 2022 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA) announced today an update to the company’s participation in the Jefferies Healthcare Conference. Mr. Michael...
Liquidia to Participate in the Jefferies Healthcare Conference
02 juin 2022 09h04 HE
|
Liquidia Corporation
MORRISVILLE, N.C., June 02, 2022 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA) announced today that Mr. Michael Kaseta, Chief Financial Officer, will participate in a fireside chat at the...
Liquidia Announces Presentations at the 2022 American Thoracic Society (ATS) International Conference
16 mai 2022 07h30 HE
|
Liquidia Corporation
MORRISVILLE, N.C., May 16, 2022 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA) (“Liquidia” or the “Company”) today announced the presentation of data related to the investigational use of...
Liquidia Reports First Quarter 2022 Financial Results and Provides Corporate Update
12 mai 2022 07h00 HE
|
Liquidia Corporation
- Secured access to new capital through debt and equity transactions - Increased utilization of Treprostinil Injection with increasing payer generic mandates - Advanced Hatch-Waxman litigation in...
Liquidia to Report First Quarter 2022 Financial Results on May 12, 2022
05 mai 2022 08h00 HE
|
Liquidia Corporation
MORRISVILLE, N.C., May 05, 2022 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA) announced today that it will report its first quarter 2022 financial results on Thursday, May 12, 2022. The...
Liquidia Corporation Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
25 avr. 2022 08h45 HE
|
Liquidia Corporation
MORRISVILLE, N.C., April 25, 2022 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA) today announced the grant of inducement stock options exercisable for an aggregate of 35,700 shares of...
Liquidia Announces Oral Presentation at the 42nd Annual Meeting of International Society for Heart and Lung Transplant (ISHLT)
20 avr. 2022 10h01 HE
|
Liquidia Corporation
MORRISVILLE, N.C., April 20, 2022 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA) (“Liquidia” or the “Company”) today announced that Sandeep Sahay, MD, from Houston Methodist Hospital will...
Liquidia Announces Closing of Public Offering of Common Stock and Full Exercise of Over-Allotment Option
18 avr. 2022 16h05 HE
|
Liquidia Corporation
MORRISVILLE, N.C., April 18, 2022 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA) (“Liquidia”) today announced the closing of its previously announced underwritten public offering of...
Liquidia Announces Pricing of Public Offering of Common Stock
12 avr. 2022 21h38 HE
|
Liquidia Corporation
MORRISVLLE, N.C., April 12, 2022 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA) (“Liquidia”) announced the pricing of an underwritten public offering of 9,803,922 shares of its common stock...
Liquidia Announces Proposed Offering of Common Stock
12 avr. 2022 16h17 HE
|
Liquidia Corporation
MORRISVILLE, N.C., April 12, 2022 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA) (“Liquidia”) announced today that it has commenced an underwritten public offering of its common stock. All...